Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger
Jonel Trebicka

Showing results (111-120 of 971) with videos related to

Pageof 98
Sort By:
Clinics in Liver Disease|April 11, 2021
Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored ApproachMathias Jachs, Thomas Reiberger
Plos One|February 4, 2015
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfectionChristian Jansen, Thomas Reiberger, Jia Huang, et al.
Clinical and Translational Gastroenterology|February 8, 2020
Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein ThrombosisMichael Praktiknjo, Jonel Trebicka, Roberto Carnevale, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2005
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosisJörg Heller, Jonel Trebicka, Thomas Shiozawa, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
Evaluation of the In Vitro and In Vivo Effects of Biglycan in Innate ImmunityJinyang Zeng-Brouwers, Lisa Sophie Huber, Rosetta Merline, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2026
Role of Gram-Negative Bacterial Infections in Acute-On-Chronic Liver FailureCamilla Cadoli, Volker Müller, Christoph Welsch, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 17, 2023
Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failurePhillipp Hartmann, Sonja Lang, Robert Schierwagen, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2019
Editorial: pressure to close the therapeutic window of non-selective beta blockers?Mattias Mandorfer, Thomas Reiberger
Journal of Hepatology|June 12, 2017
Reply to: "Beta adrenergic blockade and advanced cirrhosis: Does it really improve survival in patients with acute-on-chronic liver failure?"Thomas Reiberger, Mattias Mandorfer
Hepatology (Baltimore, Md.)|July 13, 2020
Letter to the Editor: Perioperative Presentation of COVID-19 in a Liver Transplant RecipientThomas Reiberger, Mattias Mandorfer
Pageof 98

Showing results (111-120 of 971) with videos related to

Sort By:
Pageof 98
Clinics in Liver Disease|April 11, 2021
Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers: A Tailored ApproachMathias Jachs, Thomas Reiberger
Plos One|February 4, 2015
Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfectionChristian Jansen, Thomas Reiberger, Jia Huang, et al.
Clinical and Translational Gastroenterology|February 8, 2020
Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein ThrombosisMichael Praktiknjo, Jonel Trebicka, Roberto Carnevale, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 25, 2005
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosisJörg Heller, Jonel Trebicka, Thomas Shiozawa, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
Evaluation of the In Vitro and In Vivo Effects of Biglycan in Innate ImmunityJinyang Zeng-Brouwers, Lisa Sophie Huber, Rosetta Merline, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2026
Role of Gram-Negative Bacterial Infections in Acute-On-Chronic Liver FailureCamilla Cadoli, Volker Müller, Christoph Welsch, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 17, 2023
Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failurePhillipp Hartmann, Sonja Lang, Robert Schierwagen, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2019
Editorial: pressure to close the therapeutic window of non-selective beta blockers?Mattias Mandorfer, Thomas Reiberger
Journal of Hepatology|June 12, 2017
Reply to: "Beta adrenergic blockade and advanced cirrhosis: Does it really improve survival in patients with acute-on-chronic liver failure?"Thomas Reiberger, Mattias Mandorfer
Hepatology (Baltimore, Md.)|July 13, 2020
Letter to the Editor: Perioperative Presentation of COVID-19 in a Liver Transplant RecipientThomas Reiberger, Mattias Mandorfer
Pageof 98